Le Thanh Hoa, Nguyen Nga Thi Bich
Department of Immunology, Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Clin Exp Vaccine Res. 2014 Jul;3(2):117-27. doi: 10.7774/cevr.2014.3.2.117. Epub 2014 Jun 20.
Based on hemagglutinin (HA) and neuraminidase (NA), influenza A virus is divided into 18 different HA (H1 to H18) and 11 NA types (N1 to N11), opening the possibility for reassortment between the HA and NA genes to generate new HxNy subtypes (where x could be any HA and y is any NA, possibly). In recent four years, since 2010, highly pathogenic avian influenza (HPAI) viruses of H5N1 subtype (HPAI A/H5N1) have become highly enzootic and dynamically evolved to form multiple H5 HA clades, particularly in China, Vietnam, Indonesia, Egypt, Cambodia, and Bangladesh. So far, after more than 10 years emerged in Vietnam (since late 2003), HPAI A/H5N1 is still posing a potential risk of causing outbreaks in poultry, with high frequency of annual endemics. Intragenic variation (referred to as antigenic drift) in HA (e.g., H5) has given rise to form numerous clades, typically marking the major timelines of the evolutionary status and vaccine application in each period. The dominance of genetically and antigenically diversified clade 2.3.2.1 (of subgroups a, b, c), clade 1.1 (1.1.1/1.1.2) and re-emergence of clade 7.1/7.2 at present, has urged Vietnam to the need for dynamically applied antigenicity-matching vaccines, i.e., the plan of importing Re-6 vaccine for use in 2014, in parallel use of Re-1/Re-5 since 2006. In this review, we summarize evolutionary features of HPAI A/H5N1 viruses and clade formation during recent 10 years (2004-2014). Dynamic of vaccine implementation in Vienam is also remarked.
基于血凝素(HA)和神经氨酸酶(NA),甲型流感病毒可分为18种不同的HA类型(H1至H18)和11种NA类型(N1至N11),这使得HA和NA基因之间有可能发生重配,从而产生新的HxNy亚型(其中x可以是任何一种HA,y可能是任何一种NA)。在过去四年里,自2010年以来,H5N1亚型高致病性禽流感(HPAI)病毒(HPAI A/H5N1)已高度地方性流行,并动态进化形成多个H5 HA进化枝,特别是在中国、越南、印度尼西亚、埃及、柬埔寨和孟加拉国。迄今为止,自2003年末在越南出现10多年后,HPAI A/H5N1仍然构成在家禽中引发疫情的潜在风险,并每年频繁出现地方病流行。HA(如H5)中的基因内变异(称为抗原漂移)已导致形成众多进化枝,这通常标志着每个时期进化状态和疫苗应用的主要时间线。目前基因和抗原多样化的2.3.2.1进化枝(a、b、c亚组)、1.1进化枝(1.1.1/1.1.2)的主导地位以及7.1/7.2进化枝的重新出现,促使越南需要动态应用抗原匹配疫苗,即计划在2014年进口Re-6疫苗供使用,同时自2006年以来并行使用Re-1/Re-5疫苗。在本综述中我们总结了HPAI A/H5N1病毒近10年(2004 - 2014年)的进化特征和进化枝形成情况。还阐述了越南疫苗实施情况的动态变化。